Azithromycin concentrations during long-term regimen, a pilot study in patients with MALT lymphoma
Scheibenpflug, Raphael, Obermüller, Markus, Reznicek, Gottfried, Neuper, Ortrun, Lamm, Wolfgang W., Raderer, Markus, Lagler, Heimo
Published in Scientific reports (16.09.2021)
Published in Scientific reports (16.09.2021)
Get full text
Journal Article
Prolonged follow‐up on lenalidomide‐based treatment for mucosa‐associated lymphoid tissue lymphoma (MALT lymphoma)—Real‐world data from the Medical University of Vienna
Kiesewetter, Barbara, Lamm, Wolfgang, Neuper, Ortrun, Mayerhoefer, Marius E., Simonitsch‐Klupp, Ingrid, Raderer, Markus
Published in Hematological oncology (01.10.2019)
Published in Hematological oncology (01.10.2019)
Get full text
Journal Article
Treatment of mucosa associated lymphoid tissue lymphoma with a long‐term once‐weekly regimen of oral azithromycin: Results from the phase II MALT—A trial
Lagler, Heimo, Kiesewetter, Barbara, Dolak, Werner, Obermueller, Markus, Simonitsch‐Klupp, Ingrid, Lukas, Julius, Neuper, Ortrun, Lamm, Wolfgang W., Mayerhoefer, Marius E., Raderer, Markus
Published in Hematological oncology (01.02.2019)
Published in Hematological oncology (01.02.2019)
Get full text
Journal Article
A pilot phase II study of ofatumumab monotherapy for extranodal marginal zone B‐cell lymphoma of the mucosa‐associated lymphoid tissue (MALT) lymphoma
Kiesewetter, Barbara, Neuper, Ortrun, Mayerhoefer, Marius E., Dolak, Werner, Lukas, Julius, Simonitsch‐Klupp, Ingrid, Raderer, Markus
Published in Hematological oncology (01.02.2018)
Published in Hematological oncology (01.02.2018)
Get full text
Journal Article